Selçuk Ecza Deposu Ticaret ve Sanayi Share Price

Equities

SELEC

TRESLEC00014

Pharmaceuticals

Market Closed - Borsa Istanbul 08:39:24 26/04/2024 pm IST 5-day change 1st Jan Change
53.5 TRY -4.38% Intraday chart for Selçuk Ecza Deposu Ticaret ve Sanayi -5.56% -13.15%

Financials

Sales 2024 * 126B 3.88B 324B Sales 2025 * 170B 5.26B 438B Capitalization 34.83B 1.07B 89.62B
Net income 2024 * 4.33B 134M 11.15B Net income 2025 * 6.33B 195M 16.28B EV / Sales 2024 * 0.28 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.2 x
P/E ratio 2024 *
6.89 x
P/E ratio 2025 *
5.25 x
Employees 6,025
Yield 2024 *
-
Yield 2025 *
-
Free-Float 20.01%
More Fundamentals * Assessed data
Dynamic Chart
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Selçuk Ecza Deposu Ticaret ve Sanayi A.S.(IBSE:SELEC) added to FTSE All-World Index CI
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Sel?uk Ecza Deposu Ticaret ve Sanayi A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Selçuk Ecza Deposu Ticaret Ve Sanayi A.S. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Selçuk Ecza Deposu Ticaret Ve Sanayi A.S. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Selçuk Ecza Deposu Ticaret Ve Sanayi A.S. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Selçuk Ecza Deposu Ticaret Ve Sanayi A.S. Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
More news
1 day-4.38%
1 week-5.56%
Current month+6.89%
1 month+11.69%
3 months-12.30%
6 months-2.37%
Current year-13.15%
More quotes
1 week
53.45
Extreme 53.45
57.75
1 month
48.00
Extreme 48
57.75
Current year
47.58
Extreme 47.58
66.65
1 year
26.44
Extreme 26.44
69.20
3 years
7.85
Extreme 7.85
69.20
5 years
3.77
Extreme 3.77
69.20
10 years
1.93
Extreme 1.93
69.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 68 01/77/01
Director of Finance/CFO 76 01/96/01
Chief Administrative Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 68 01/77/01
Director/Board Member 68 01/72/01
Director/Board Member 72 01/72/01
More insiders
Date Price Change Volume
26/24/26 53.5 -4.38% 2,386,882
25/24/25 55.95 +1.27% 1,323,376
24/24/24 55.25 0.00% 1,074,291
22/24/22 55.25 -2.47% 1,864,139
19/24/19 56.65 +0.18% 1,770,505

Delayed Quote Borsa Istanbul, April 26, 2024 at 08:39 pm IST

More quotes
Selcuk Ecza Deposu Ticaret ve Sanayi AS (Selcuk Ecza) is a Turkey-based medical warehousing company that serves as the distribution channel between pharmaceutical companies, pharmacies and hospitals. The Company distributes pharmaceutical products, as well as cosmetics, personal care, infant food, vitamins, medical and similar products. The Company operates through a network of five branches located in Ankara, Samsun, Izmir, Konya and Antalya. As of December 31, 2011, the Company’s subsidiaries included As Ecza Deposu Ticaret AS, which is engaged in operating as a pharmacy depot through four branches located in Ankara, Kayseri, Izmir and Konya, and Selcuk Ecza Deposu Dis Tic AS, which is active in the export and import of a range of drugs and patent medicines, medical supplies together with pharmacy depot operations.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
53.5 TRY
Average target price
68.89 TRY
Spread / Average Target
+28.77%
Consensus

Quarterly revenue - Rate of surprise